Breaking
•OpenAI sued over claim that ChatGPT drafted lethal poisoning plan•Canada keeps a lid on immigration, locks in lower targets through 2029•Police searching for man who went missing while making DoorDash deliveries - WPXI•High school football playoffs: Raines makes Open division as massive playoff road awaits Vikings - News4JAX•Ravens’ Lamar Jackson Predicted to Sign Record-Breaking Extension - Yahoo Sports•Macklemore says Climate Pledge Arena turned down ‘Free Palestine Tour’ - Yakima Herald-Republic•Midterm elections fall short of a “green wave,” but voters still care about climate and sustainability issues - Aspen Public Radio•Everton storms back to beat Coventry and leapfrog Liverpool into 5th place - Seattle Post-Intelligencer•'Two games we have thrown away' - Yahoo Sports•“Getting to play more sure helped,” he says. He points … - Yahoo Sports•Kristaps Porzingis Makes Announcement on NBA Future Due to Health - Yahoo Sports•Paul Catalina Takes Sports and Comedy Live with “The Sports Game Podcast” - KWTX•Injury Report: Seahawks rule out 7 players vs Cardinals - Seattle Sports•Top 10 Virtual Classroom Software Development Companies in Australia - WhaTech•TELUS Reports Third Quarter 2026 Results, Demonstrates Continued Discipline in Core Telecom; Advances Transformation Strategy - PR Newswire•What to Know About Stephen Miller, Trump’s New Chief of Staff - The New York Times•With Stephen Miller pick, Trump readies for a battle - BBC•Leo appeals for universal healthcare as Latin America visit begins - The Tablet•Pope Leo XIV’s visit to Latin America, in photos - WTOP News•Never rivals, always allies: How Dakar 2026 helped forge an African triathlon sisterhood - Olympic Channel•OpenAI sued over claim that ChatGPT drafted lethal poisoning plan•Canada keeps a lid on immigration, locks in lower targets through 2029•Police searching for man who went missing while making DoorDash deliveries - WPXI•High school football playoffs: Raines makes Open division as massive playoff road awaits Vikings - News4JAX•Ravens’ Lamar Jackson Predicted to Sign Record-Breaking Extension - Yahoo Sports•Macklemore says Climate Pledge Arena turned down ‘Free Palestine Tour’ - Yakima Herald-Republic•Midterm elections fall short of a “green wave,” but voters still care about climate and sustainability issues - Aspen Public Radio•Everton storms back to beat Coventry and leapfrog Liverpool into 5th place - Seattle Post-Intelligencer•'Two games we have thrown away' - Yahoo Sports•“Getting to play more sure helped,” he says. He points … - Yahoo Sports•Kristaps Porzingis Makes Announcement on NBA Future Due to Health - Yahoo Sports•Paul Catalina Takes Sports and Comedy Live with “The Sports Game Podcast” - KWTX•Injury Report: Seahawks rule out 7 players vs Cardinals - Seattle Sports•Top 10 Virtual Classroom Software Development Companies in Australia - WhaTech•TELUS Reports Third Quarter 2026 Results, Demonstrates Continued Discipline in Core Telecom; Advances Transformation Strategy - PR Newswire•What to Know About Stephen Miller, Trump’s New Chief of Staff - The New York Times•With Stephen Miller pick, Trump readies for a battle - BBC•Leo appeals for universal healthcare as Latin America visit begins - The Tablet•Pope Leo XIV’s visit to Latin America, in photos - WTOP News•Never rivals, always allies: How Dakar 2026 helped forge an African triathlon sisterhood - Olympic Channel
clinical_trials

Gene Therapy Under Scrutiny After Nine Tumor Reports

Confidence86·multiple reportsImportance88NP-EVT-20261106-FA2E050

(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor cases were...

Read the original at the primary source
Gene Therapy Under Scrutiny After Nine Tumor Reports
11/6/2026, 10:27:17 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —